Apixaban versus warfarin in Patients with Atrial Fibrillation in relation to Prior Warfarin Use: Insights from the ARISTOTLE trial

被引：0
|
作者：
Garcia, David A. [1 ]
Alexander, John H. [2 ]
Lopes, Renato D. [2 ]
Thomas, Laine [3 ]
Yang, Hongqiu [3 ]
Ansell, Iack [4 ]
Commerford, Patrick [5 ]
Flaker, Greg [6 ]
Lanas, Fernando [7 ]
Mohan, Puneet [8 ]
Vinereanu, Dragos [9 ]
Xavier, Denis [10 ]
Granger, Christopher [2 ]
Wallentin, Lars [11 ]
机构：
[1] Univ New Mexico, Albuquerque, NM 87131 USA
[2] Duke Univ, Durham, NC USA
[3] Duke Univ, Clin Rsch Inst, Durham, NC USA
[4] Lenox Hill Hosp, New York, NY 10021 USA
[5] Univ Cape Town, Observatory, South Africa
[6] Univ Missouri, Columbia, MO USA
[7] Univ La Frontera, Temuco, Chile
[8] Bristol Myers Squibb Co, Cardiovasc Dev, Princeton, NJ USA
[9] Univ Hosp Bucharest, Bucharest, Romania
[10] St Johns Rsch Inst, Bangalore, Karnataka, India
[11] Uppsala Univ, Uppsala, Sweden
来源：
CIRCULATION | 2012年 / 126卷 / 21期
关键词：
Anticoagulation; Atrial fibrillation; Stroke;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
14771
引用
收藏
页数：2
相关论文
共 50 条
  • [1] APIXABAN VERSUS WARFARIN FOR PATIENTS WITH RECENT ONSET ATRIAL FIBRILLATION: INSIGHTS FROM THE ARISTOTLE TRIAL
    Guimaraes, Patricia
    Alexander, John
    Wojdyla, Daniel
    Thomas, Laine
    Alings, Marco
    Flaker, Greg
    Al-Khatib, Sana
    Hanna, Michael
    Wallentin, Lars
    Granger, Christopher
    Lopes, Renato
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 691 - 691
  • [2] Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Left Ventricular Hypertrophy Insights From the ARISTOTLE Trial
    Al-Khatib, Sana M.
    Mulder, Hillary
    Wojdyla, Daniel
    Lopes, Renato D.
    Wallentin, Lars
    Alexander, John H.
    Hijazi, Ziad
    Goto, Shinya
    Granger, Christopher B.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2021, 14 (03): : 359 - 361
  • [3] Apixaban versus warfarin in patients with atrial fibrillation: examination of ARISTOTLE
    Szczerba, Ewa
    KARDIOLOGIA POLSKA, 2012, 70 (02) : 196 - 200
  • [4] Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial
    Alexander, Karen P.
    Brouwer, Marc A.
    Mulder, Hillary
    Vinereanu, Dragos
    Lopes, Renato D.
    Proietti, Marco
    Al-Khatib, Sana M.
    Hijazi, Ziad
    Halvorsen, Sigrun
    Hylek, Elaine M.
    Verheugt, Freek W. A.
    Alexander, John H.
    Wallentin, Lars
    Granger, Christopher B.
    AMERICAN HEART JOURNAL, 2019, 208 : 123 - 131
  • [5] Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: Results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
    Garcia, David A.
    Wallentin, Lars
    Lopes, Renato D.
    Thomas, Laine
    Alexander, John H.
    Hylek, Elaine M.
    Ansell, Jack
    Hanna, Michael
    Lanas, Fernando
    Flaker, Greg
    Commerford, Patrick
    Xavier, Denis
    Vinereanu, Dragos
    Yang, Hongqiu
    Granger, Christopher B.
    AMERICAN HEART JOURNAL, 2013, 166 (03) : 549 - 558
  • [6] Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial
    Melloni, Chiara
    Dunning, Allison
    Granger, Christopher B.
    Thomas, Laine
    Khouri, Michel G.
    Garcia, David A.
    Hylek, Elaine M.
    Hanna, Michael
    Wallentin, Lars
    Gersh, Bernard J.
    Douglas, Pamela S.
    Alexander, John H.
    Lopes, Renato D.
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (12): : 1440 - +
  • [7] Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and active cancer: insights from the ARISTOTLE trial
    Melloni, C.
    Dunning, A.
    Granger, C. B.
    Thomas, L.
    Khouri, M.
    Garcia, D. A.
    Hylek, E. M.
    Wallentin, L.
    Gersh, B. J.
    Douglas, P. S.
    Alexander, J. H.
    Lopes, R. D.
    EUROPEAN HEART JOURNAL, 2016, 37 : 234 - 234
  • [8] Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
    Hohnloser, Stefan H.
    Hijazi, Ziad
    Thomas, Laine
    Alexander, John H.
    Amerena, John
    Hanna, Michael
    Keltai, Matyas
    Lanas, Fernando
    Lopes, Renato D.
    Lopez-Sendon, Jose
    Granger, Christopher B.
    Wallentin, Lars
    EUROPEAN HEART JOURNAL, 2012, 33 (22) : 2821 - 2830
  • [9] History of Bleeding and Outcomes with Apixaban versus Warfarin in Patients with Atrial Fibrillation in the ARISTOTLE Trial
    De Caterina, Raffaele
    Andersson, Ulrika
    Alexander, John H.
    Bahit, M. Cecilia
    Commerford, Patrick J.
    Goto, Shinya
    Granger, Christopher B.
    Hanna, Michael
    Held, Claes
    Hohnloser, Stefan H.
    Hylek, Elaine M.
    Lanas, Fernando
    Lopes, Renato D.
    Lopez-Sendon, Jose L.
    Wallentin, Lars
    CIRCULATION, 2014, 130
  • [10] Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight Insights From the ARISTOTLE Trial
    Hohnloser, Stefan H.
    Fudim, Marat
    Alexander, John H.
    Wojdyla, Daniel M.
    Ezekowitz, Justin A.
    Hanna, Michael
    Atar, Dan
    Hijazi, Ziad
    Cecilia Bahit, M.
    Al-Khatib, Sana M.
    Luis Lopez-Sendon, Jose
    Wallentin, Lars
    Granger, Christopher B.
    Lopes, Renato D.
    CIRCULATION, 2019, 139 (20) : 2292 - 2300
12345